DEXCO S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.28 BRL | +1.53% |
|
+0.97% | -9.79% |
| Mar. 07 | Transcript : Dexco S.A., Q4 2023 Earnings Call, Mar 07, 2024 | |
| Mar. 07 | Dexco S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Evolution of the average Target Price on Dexco S.A.
Price target over the last 5 years
History of analyst recommendation changes
322abef2c80ee40ce91.sirMhspxAROL5mPMR4ZtEFzooSxhEXpc0VpfTNvDplY.-3i5wokUUGrOqFSDEO5AfAu_0RUpJDw-jgMIGJqKngOCRbz2gEhmI7vTVw~fb5e812782edc57badfa7d3b3af76928
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
7.35
BRL
Average target price
10.31
BRL
Spread / Average Target
+40.31%
High Price Target
13
BRL
Spread / Highest target
+76.87%
Low Price Target
8.5
BRL
Spread / Lowest Target
+15.65%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
A-
EPS Revisions
- Stock Market
- Equities
- DXCO3 Stock
- Consensus Dexco S.A.
